3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
23
Lung Neoplasms
12
Prostatic Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
8
Breast Neoplasms
5
Stomach Neoplasms
4
Prostatic Neoplasms, Castration-Resistant
4
Neoplasms
4
Neoplasm Metastasis
3
Endometrial Neoplasms
3
Carcinoma, Transitional Cell
3
Carcinoma
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Carcinoma
2
Melanoma
2
Lymphoid Interstitial Pneumonia
2
Head and Neck Neoplasms
2
HER2-positive Breast Cancer
2
Esophageal Neoplasms
2
Anatomic Stage I Breast Cancer AJCC v8
2
Vaccinia
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Tongue Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Solid Tumors
1
Interventions
Cyclophosphamide
29
fludarabine
19
fludarabine phosphate
13
Methotrexate
12
blinatumomab
11
Whole-Body Irradiation
11
Vincristine
8
Tacrolimus
8
Mycophenolic Acid
8
Cytarabine
8
Dexamethasone
7
Cyclosporine
7
Busulfan
7
merphos
6
Thiotepa
6
Specimen Handling
6
Mercaptopurine
6
Melphalan
6
Granulocyte Colony-Stimulating Factor
6
pegaspargase
5
Peripheral Blood Stem Cell Transplantation
5
Mesna
5
Filgrastim
5
venetoclax
4
prednylidene
4
Stem Cell Transplantation
4
Sirolimus
4
Prednisone
4
Leukapheresis
4
Immunotherapy, Adoptive
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Docetaxel
×
30 days
×
Clear all
No trials found.